Welcome to ATMP Sweden!
'ATMP Sweden' is the national network of Sweden's activities within medicines based on genes, cells or tissue engineering, classified as Advanced Therapy Medicinal Products (ATMPs) in Europe. Our goal is to promote the collaboration and communication needed for accelerated, effective ATMP based patient solutions.
Who are we?
Driving ATMP technological developments, research translation and manufacturing capabilities.
Work with us towards making ‘Sweden a world leader in advanced therapies by 2030’
Competence Center for the development of next generation NK cell-based cancer immunotherapies.
Subscribe to our mailing list
Subscribe to receive our quarterly newsletter and updates on the next ATMP Sweden conference.
Follow us on LinkedIn!
ATMP world tour April 26-30, 2021
News
Inaugural “ATMP world tour” 2021
2021-03-30
Driving International dialogue in cell and gene therapy
Read more
ATMP SWEDEN NEWSLETTER FEBRUARY 2021
2021-02-16
Catch up on the latest including Swedish COVID-19 ATMPs and the ATMP world tour 2021!
Read moreSDP1 permits and standards for cellular ATMPs
2021-02-14
Donors, manufacture, pharmacy and clinic....what permits are needed by who and from whom? What quality standards?
Read moreResources
Find information, links and support for developing your ATMP commercial model.
Use this guide to navigate development of an ATMP through manufacture and Clinical Trial Application.
Find or advertise ATMP relevant job opportunities here!
What are ATMPs?
Events
Other collaborating national projects
VOG cell is responsible for ensuring Swedish GMP manfacturing facilities function at the highest level and are compliant with current regulations.
AdBIOPRO is developing Continuous Processing of emerging potent therapeutic products such as recombinant viral vector and cell Products.
Sweden are world leader in NK cell research and this group are world leaders in NK cell therapies for patients!
See all ATMP relevant organisations here